Showing 1 - 1 of 1
Phusadee Arunmas, Published on 05/05/2021
» The Department of Intellectual Property has rejected the developer of the drug favipiravir's latest patent application, paving the way for local production of the antiviral medication now widely used to treat Covid-19 patients.